George Clinical has been recognized by PharmaTech Outlook, an industry trade journal, in the annual listing of the top 10 companies operating in the Asia-Pacific region that are at the forefront of providing clinical trial consulting services and transforming businesses.
The Top 10 Clinical Trial Management recognition is timely given George Clinical expansion in multiple global markets. The Journal’s editorial team writes:
“…how do small and medium-sized biotech companies conduct clinical trials in a better, faster, cheaper, smarter, and more consistent manner? It is hard to find a clinical research organization (CRO) better equipped to answer this question than George Clinical. As one of the leading global CROs, with 20 years of industry experience, George Clinical provides a full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. With operations throughout the Asia-Pacific region, the US, and Europe, George Clinical is singularly focused on one mission: to empower companies with its global service delivery, world-class scientific leadership and therapeutic strengths in renal, cardiovascular, oncology, and respiratory disease for improving the health of millions of people worldwide.”
